The NKCC1 antagonist bumetanide mitigates interneuronopathy associated with ethanol exposure in utero
Year: 2019
Type: article
Abstract: Prenatal exposure to ethanol induces aberrant tangential migration of corticopetal GABAergic interneurons, and long-term alterations in the form and function of the prefrontal cortex. We have hypothesized that interneuronopathy contributes significantly to the pathoetiology of fetal alcohol spectrum disorders (FASD). Activity-dependent tangential migration of GABAergic cortical neurons is driven by depolarizing responses to ambient GABA present in the cortical enclave. We found that ethanol exposure potentiates the depolarizing action of GABA in GABAergic cortical interneurons of the embryonic mouse brain. Pharmacological antagonism of the cotransporter NKCC1 mitigated ethanol-induced potentiation of GABA depolarization and prevented aberrant patterns of tangential migration induced by ethanol in vitro. In a model of FASD, maternal bumetanide treatment prevented interneuronopathy in the prefrontal cortex of ethanol exposed offspring, including deficits in behavioral flexibility. These findings position interneuronopathy as a mechanism of FASD symptomatology, and posit NKCC1 as a pharmacological target for the management of FASD.
Source: eLife
DOI: 10.7554/elife.48648
Institutions: Dartmouth College, University of Minnesota
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,500
Awards: The chloride cotransporter NKCC1 in the embryonic etiology and treatment of FASD, Pharmacologically targeting the NKCC1 chloride cotransporter in utero for FASD, Ethanol, chloride, calcium and growth cone dynamics in embryonic GABAergic interneurons, Ethanol Exposure In Utero and Interneuronopathy in the Medial Prefrontal Cortex, G3608891759, G5520316217, G8776983472, G9000075325, G9000123624
OpenAlex ID: W2975310787
